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Cell migration requires coordination between integ-
rin-mediated cell adhesion to the extracellular matrix
and force applied to adhesion sites. Talin plays a key
role in coupling integrin receptors to the actomyosin
contractile machinery, while deleted in liver cancer 1
(DLC1) is a Rho GAP that binds talin and regulates
Rho, and therefore actomyosin contractility. We
show that the LD motif of DLC1 forms a helix that
binds to the four-helix bundle of the talin R8 domain
in a canonical triple-helix arrangement. We demon-
strate that the same R8 surface interacts with the
paxillin LD1 and LD2 motifs. We identify key charged
residues that stabilize the R8 interactions with LD
motifs and demonstrate their importance in vitro
and in cells. Our results suggest a network of
competitive interactions in adhesion complexes
that involve LD motifs, and identify mutations that
can be used to analyze the biological roles of specific
protein-protein interactions in cell migration.
INTRODUCTION
Integrin-mediated cell adhesion to the extracellular matrix (ECM)
involves the assembly of dynamic adhesion complexes and re-
quires the spatial and temporal coordination of signaling and
force-transmitting events (Gardel et al., 2010; Wehrle-Haller,
2012). Such complexes form on the cytoplasmic tails of integrin
receptors and mature into larger structures called focal adhe-
sions (FA) in response to force exerted by the actomyosin con-
tractile apparatus (Roca-Cusachs et al., 2012). The dimeric
adaptor proteins talin1 and talin2 (molecular weight 270 kDa)
play a key role in the assembly of adhesion complexes (Zhang
et al., 2008), and talin-null cells cannot adhere or spread on
ECM, a phenotype corrected by expression of talin cDNAs (Athe-
rton et al., 2015).
Talin comprises an N-terminal FERM domain (50 kDa) that
binds to and activates integrins, connected to a large flexible1130 Structure 24, 1130–1141, July 6, 2016 ª 2016 The Author(s). Pu
This is an open access article under the CC BY license (http://creativerod (200 kDa) that interacts with multiple ligands, including vin-
culin and F-actin (Calderwood et al., 2013). Integrin activation is
implicated in cancer progression (reviewed in Seguin et al.,
2015), and talin overexpression may therefore contribute to can-
cer metastasis (reviewed in Desiniotis and Kyprianou, 2011). The
talin rod constitutes a force-sensing module that regulates the
assembly and maturation of adhesion complexes, and is
composed of 13 four- and five-helical bundles connected by
short linkers, forming an extended flexible chain (Figure 1A)
(Goult et al., 2013b). Several rod domains contain cryptic vinculin
binding sites (VBSs) that become exposed as the talin domains
unfold in response to force, enhancing vinculin binding (del Rio
et al., 2009; Fillingham et al., 2005; Papagrigoriou et al., 2004;
Yao et al., 2014). Disruption of the talin force-sensing mecha-
nism has strong effects on adhesion assembly, cell polarization,
and cell migration (Atherton et al., 2015).
Talin also binds a number of proteins that regulate adhesion
dynamics, including the Rap1-GTP interacting protein RIAM
(Goult et al., 2013a; Lee et al., 2009), the Rac GEF Tiam1
(Wang et al., 2012), and the Rho GAP DLC1 (Li et al., 2011).
Recruitment of Tiam1 and DLC1 to adhesion complexes by talin
is likely to have complementary effects, balancing Rac and Rho
activity, thus creating a feedback mechanism between actin
polymerization, membrane protrusion, assembly of nascent ad-
hesions, actomyosin-driven FA maturation, and FA turnover
(Devreotes and Horwitz, 2015; Lawson and Burridge, 2014).
The DLC1 binding site in talin has been mapped by deletion
analysis to the four-helix R8 domain (Li et al., 2011) that forms
a unique protrusion in the C-terminal part of the rod that is
otherwise composed of a linear chain of five-helix bundles (Fig-
ure 1A) (Gingras et al., 2010). Interestingly, R8 also contains
binding sites for RIAM and vinculin, suggesting that the three li-
gands may compete for binding (Goult et al., 2013b). The talin
binding site (TBS) in DLC1 contains an LD-like motif that fea-
tures in a wide range of other proteins, including the FA protein
paxillin (Alam et al., 2014). The TBS in DLC1 interacts with the
FA-targeting (FAT) domain of FAK (Li et al., 2011), which also
binds the LD motifs in paxillin (Alam et al., 2014). The DLC1 in-
teractions with talin and FAK contribute to the biological activity
of DLC1, including its tumor-suppressor activity, establishing
the physiological importance of these interactions (Li et al.,
2011).blished by Elsevier Ltd.
commons.org/licenses/by/4.0/).
Figure 1. DLC1(467–489) Interacts with the Talin R8 Domain
(A) Model of the talin rod based on the structures of individual domains.
Domain R8 interacts with DLC1.
(B) Domain composition of DLC1. The location of the talin binding site (TBS) in
the largely unstructured serine-rich linker region is indicated.
(C) Secondary structure prediction for the TBS in DLC1, which includes an LD
motif marked by the red box. ‘‘h’’ denotes a region of high helical propensity
and ‘‘c’’ a random coil region. Fragments used in this study are indicated by the
thick blue lines.
(D) Superposition of the 1H,15N-HSQC spectra (298 K, 800 MHz) of 100 mM
talin R8 domain in the free form (blue) and in the presence of 4-fold excess of
DLC1(467–489) (red).
See also Figure S3.Here we report the crystal structure of the talin R7R8 domains
in complex with the TBS of DLC1; the DLC1 LDmotif forms a he-
lix that binds to talin R8 in a consensus triple-helix arrangement
between the contacting DLC1 and talin helices. We identify the
main electrostatic interactions that stabilize the complex and
use mutations to demonstrate the importance of the talin/
DLC1 interaction in cells. Based on the talin/DLC1 structure,
we predicted that talin R8 might also bind paxillin LD motifs;
we demonstrate such an interaction by nuclear magnetic reso-
nance (NMR) and glutathione S-transferase (GST) pull-downs,and show that the talin R8 rod domain plays a significant role
in recruiting paxillin to FAs. We propose that LD-motif recogni-
tion sites in adhesion proteins such as talin and FAK are to a large
degree interchangeable, creating a network of competing pro-
tein-protein interactions that regulate the properties of adhesion
complexes.
RESULTS
Structure of the DLC1/Talin Complex
The TBS in DLC1 has been shown to require an 8-residue pep-
tide 469LDDILYHV476 located in the largely unstructured linker re-
gion (residues 78–639) between the SAM and GAP domains of
DLC1 (Figure 1B) (Li et al., 2011). However, consensus second-
ary structure prediction using the NPSA server (https://
npsa-prabi.ibcp.fr) indicates that the DLC1 peptide is located
at the N terminus of a larger region with high helical propensity
(residues 465–488, Figure 1C), suggesting that the TBS in
DLC1 may extend beyond residues 469–476. To explore this
possibility, we used two synthetic DLC1 peptides (residues
461–489 and 467–489) that span the putative helical region.
The shorter fragment starts with a proline residue, which usually
disrupts helical structure, and is often located at the beginning or
end of a helix.
The minimal talin fragment required for interaction with DLC1
(Li et al., 2011) maps to the four-helix bundle R8 domain in the
talin rod (Figure 1A) (Gingras et al., 2010; Goult et al., 2013b).
Addition of the DLC1(467–489) peptide induced large chemi-
cal-shift changes in the heteronuclear single-quantum coher-
ence (HSQC) spectra of 15N-labeled talin R8 (Figure 1D) as did
the larger peptide (data not shown), demonstrating the formation
of a stable complex. Although the majority of resonances
showed significant chemical-shift changes, the overall pattern
of cross-peaks was similar to that of free R8, suggesting that
the R8 fold does not change upon DLC1 binding.
The shorter DLC1(467–489) peptide was less soluble than the
longer fragment, and was therefore less suitable for the NMR
titration experiments. However, its lower solubility favored crys-
tallization of a DLC1 peptide/talin complex. For these reasons,
we used the longer DLC1 fragment for solution binding studies
and the shorter fragment for crystallization experiments. We
crystallized a complex of DLC1(467–489) with the talin R7R8
fragment, the structure of which we previously determined in
the free form (Gingras et al., 2010), and solved the structure of
the complex by molecular replacement (Figure 2A; statistics in
Table 1). As in the free form, the R7R8 talin rod fragment adopts
a unique fold where the R8 four-helix bundle is inserted into the
loop connecting helices a3 and a4 of the R7 five-helix bundle.
Individually, the structures of R7 and R8 in the DLC1 complex
are nearly identical to that of the free form (root-mean-square
deviation [RMSD] 0.35 A˚ and 1.75 A˚, respectively), the main
difference being the relative orientation of the two domains
(Figure 2B).
The linker region between R7 and R8 is well defined in the
crystal structure and shows clear electron density at the 1s level.
It forms a twisted, two-stranded, anti-parallel b sheet stabilized
by hydrogen bonds. Each end of the linker has a pair of residues
that make close contacts with the helical bundles (Figures 2B
and 2C). Despite the different angle between the R7 and R8Structure 24, 1130–1141, July 6, 2016 1131
Figure 2. Structure of the Talin/DLC1
Complex
(A) Cartoon representation of the X-ray structure of
the talin R7R8 fragment (green) in complex with
DLC1(467–489) (orange).
(B) Superposition of the crystal structure of R7R8
in the free form (cyan) and in complex with
DLC1(467–489) (green) aligned on the R7 domain.
Residues at the ends of the linker regions between
R7 and R8 are shown in stick representation (red)
and labeled.
(C) Two-stranded anti-parallel twisted b sheet
formed in the linker region. Side chains of the
residues highlighted in (B) are shown in the stick
representation and labeled.
(D) Comparison of the structure of the talin R8/
DLC1(467–489) complex (left) and the talin R10
domain (PDB: 2KVP; right). The DLC1 helix and
a0 helix of talin R10 are highlighted in orange.
(E) Topology of the talin R8/DLC1(467–489) com-
plex (left) and talin R10 (right).
See also Figure S1.domains in the complex and free forms, these contacts aremain-
tained in both structures, suggesting that the freedom in domain
orientation is mainly defined by the twist and bend of the b-sheet
linker. The linker may increase the stability of both domains by
bringing together the ends of the helices connected to the linker.
In support of the latter possibility, we found a strong effect of sur-
face mutations (R1523E, K1530E, and K1544E) on the solubility
of the isolated R8 domain, likely caused by partial unfolding. The
same mutations did not affect the fold of the R7R8 double
domain (see later).
As expected from sequence analysis andNMRdata, the DLC1
peptide forms an a helix that interacts only with the talin R8
domain (Figures 2A and 2D). The peptide is well defined in the
structure, with clear electron density at the 1s level (Figure S1A)
and average B-factor values similar to those of the protein
(Table 1). Only limited crystal packing contacts were observed
between the external surface of the DLC1 helix and the edge
of the R7 domain of the neighboring molecule (Figure S1B).
The minimal DLC1 binding region (469–476) identified by Li
et al. (2011) corresponds only to the N-terminal half of the
DLC1 helix, justifying the use of the extended fragment. The helix
starts at E468, with the preceding Pro residue having an
extended conformation. At the C terminus, the helix ends at
W486 with the adjacent SEK sequence (Figure 1C), forming an
extended structure.
The DLC1/Talin R8 Complex Resembles a Talin
Five-Helix Bundle
The DLC1 helix docks into the hydrophobic groove formed by
helices a2 and a3 of talin R8 (Figures 2 and 3), forming a canon-
ical left-handed anti-parallel triple-helix coiled-coil arrangement
(Figure S1C) (Lupas and Gruber, 2005). The topology and struc-
ture of the DLC1(467–489) complex with talin R8 have a striking
resemblance to the five-helix bundles of the talin rod (Figures 2D1132 Structure 24, 1130–1141, July 6, 2016and 2E). The DLC1 helix is equivalent to the N-terminal helix
(designated as a0) of the five-helix bundle that is located at the
distant interface between helices a2 and a3 of the four-helix
core of the structure in a cross-over arrangement (Goult et al.,
2010, 2013b).
As part of the five-helix bundle, the a0 helix makes a set of hy-
drophobic contacts with the four-helix core. These contacts
are mediated by aliphatic side chains located on the hydropho-
bic face of the amphipathic helix a0, which fits into the hydropho-
bic pockets at the interface between helices a2 and a3, following
the general principle of ‘‘knobs-into-holes’’ packing found in
helical bundles (Lupas and Gruber, 2005). The a0, a2, and a3
form a left-handed anti-parallel triple-helix coiled coil that is
similar to the triple-helix coiled coil formed by DLC1 with the
a2-a3 hairpin of R8 in the complex. The overall structure of the
five-helix bundles of the talin rod can thus be classified as
conjoined three-/four-stranded coiled coils (Moutevelis and
Woolfson, 2009), adding a significant number of new members
to this rare fold.
DLC1 Recognition by the Talin R8 Domain
The contacts between DLC1 and R8 are mediated by the hydro-
phobic side chains of L469, I472, V476, M479, V483, and W486
located on the hydrophobic face of the DLC1 helix (Figure 3D).
These residues follow a typical heptad repeat of a coiled coil
(Lupas and Gruber, 2005), starting with L468 in position ‘‘a’’
(marked by letters at the top of Figure 3E); the contacting resi-
dues occupy positions ‘‘a’’ and ‘‘d’’ of the three sequential re-
peats. Additional hydrophobic contacts are made by the side
chain of L473 in position ‘‘e’’ of the first repeat. At the N-terminal
end of the DLC1 helix, corresponding to the LD motif, residues
L469, I472, L473, and V476 are embedded between the hydro-
phobic side chains of L1492 of the R8 a2 helix, and V1540,
K1541, and I1543 of the a3 helix in a ‘‘knobs-into-holes’’
Table 1. Data Collection and Refinement Statistics of the R7R8/
DLC1 Complex
Data Collection
Beamline I03
Wavelength (A˚) 0.97
Resolution range (A˚) 55.18–2.1(2.2–2.1)
Space group P3121
Unit cell
a, b, c (A˚) 73.26, 73.26, 111.82
a, b, g () 90, 90, 120
Unique reflections 20,847
Multiplicity 7.8 (7.6)
Completeness (%) 100
Mean I/s 10.11 (2.8)
Wilson B factor (A˚2) 31.16
Rmerge (%) 12.8 (65.8)
CC1/2 0.998 (0.79)
Refinement
Unique reflections 19,777
Rwork (%) 17.66 (20.3)
Rfree (%) 23.06 (26.4)
No. of atoms 2,635
Macromolecule 2,456
Protein residues 329
RMSD bonds (A˚) 0.008
RMSD angles () 0.9
Ramachandran favored (%) 98.2
Ramachandran allowed (%) 1.8
Average B factors (A˚2)
R7R8 main chain 34.393
R7R8 side chain 42.621
DLC1 main chain 28.756
DLC1 side chain 38.327
Solvent 39.68
Rfree is calculated using 5% of data isolated from refinement. Data from
highest-resolution shell are in parentheses.arrangement typical for the coiled-coil packing, creating a small
hydrophobic core (Figure 3B). The negatively charged DLC1 res-
idue D470 that is conserved within LD motifs (the ‘‘D’’ residue)
makes direct contact with the positively charged side chain of
K1544 in R8. The complementary hydrophobic surface of R8,
together with the positively charged K1544, creates an LD-
recognition box that matches the consensus features of LD bind-
ing motifs (Hoellerer et al., 2003) (Figure 3C).
The middle of the a2-a3 binding surface on talin R8 consists of
small non-polar side chains that accommodate the hydrophobic
residues V476, M479, and V483 in the middle of the DLC1 helix
without creating any matching contacts (Figure 3B). This region
generally shields the hydrophobic surface of the DLC1 helix
from solvent, but is unlikely to make strong contributions to
selectivity or affinity. The C-terminal hydrophobic residues
V483 and W485 of DLC1 are packed against each other and
the side chains of K1510 and V1526 in R8, creating a small hy-drophobic cluster that stabilizes the end of the DLC1 helix (Fig-
ures 3B–3D).
The polar side chains of Q480 andN484 in DLC1 (positions ‘‘e’’
and ‘‘b’’ of the heptad repeat) make contacts with the matching
polar groups of N1534 and N1538 at the edge of the R8 a2-a3
hydrophobic patch, creating a polar ridge (Figure 3B). This ridge
is extended by charge contacts between E488 of DLC1, which is
wedged between the positively charged groups R1523 and
K1530 of R8. These polar residues are not part of the LD motif,
but generate DLC1-specific contacts that may contribute to
recognition. The interaction between DLC1 E488 and R1523
and K1530 of talin R8 may explain why the DLC1 helix is disrup-
ted at the C terminus: in a continuous helix, E488 would be point-
ing away from the talin surface.
We tested the role of positively charged residues in talin by
selectively reversing the charge of R1523, K1530, and K1544
(Figures 3B and 4A). Surprisingly, when these mutations were
introduced into the isolated R8 domain, a large fraction of the
protein was found in inclusion bodies and the soluble fraction
contained partially degraded protein. These observations sug-
gest that although the mutations were at solvent-exposed posi-
tions, the R8 fold was destabilized. In contrast, the talin R7R8
fragment bearing the same mutations was soluble and stable.
Similarity of the NMR spectra of the wild-type and mutated
R7R8 demonstrate that the protein fold was not affected.
Single-residue mutations in talin R8 had variable effects on
DLC1 binding to talin. The spectral changes for the R1523E talin
R7R8 mutant were the closest to those of wild-type, with large
shifts and broadening of the signals indicating minimal effects
on DLC1(461–489) binding (Figure S2A). Somewhat reduced
shift changes and significantly less broadening was observed
for the K1544E mutation (Figure 4C), and very limited shift
changes with no additional broadening were observed for the
K1530E mutant (Figure 4D). From these results, we conclude
that K1530 makes the largest contribution to the interaction
with DLC1. The contribution of K1544 is significant, but smaller,
while the contribution of R1523 is negligible. However, none of
the single mutations completely abolished the interaction with
DLC1. To enhance the effects of the mutations, we generated
the K1530E/K1544E double mutant; this 2E R7R8 double mutant
showed negligible chemical-shift changes on addition of DLC1
(Figure 4E), effectively disrupting the interaction between talin
R8 and DLC1.
To validate the ion pairing between D470 and E488 of DLC1,
and K1530 and K1544 of talin R7R8, we introduced charge-
reversal mutations D470K/E488K in DLC1, complementary to
K1530E/K1544E of talin. The addition of the double D470K/
E488K DLC1 mutant to the K1530E/K1544E talin R7R8 induced
significant chemical-shift changes (Figure 4F). These changes
were not as large as those observed with the wild-type proteins,
but were comparable with changes observed with the K1530E
mutant. The D470K/E488K DLC1 mutant also showed some
interaction with the wild-type R7R8, although not as strong as
with the wild-type DLC1 (Figure S2B). The incomplete recovery
of the interaction and residual binding of the mutated DLC1
may reflect the ability of the peptide to adopt a slightly different
conformation in the complex due to its small size and flexibility.
Although further optimization will be required to enhance the
interaction between the DLC1/talin R8 charge-reversal mutants,Structure 24, 1130–1141, July 6, 2016 1133
Figure 3. Recognition of the DLC1(467–489)
Helix by the Talin R8 Domain
(A) Position of the DLC1(467–489) helix (orange)
relative to the a2 and a3 helices of talin R8
(green).
(B) DLC1 and talin residues that make contacts in
the complex. Side chains of the residues involved
in hydrophobic interactions are shown as balls;
charged and hydrophilic interactions are shown as
balls and sticks. Blue rectangle identifies the
‘‘polar ridge’’ of the complex.
(C) DLC1-interacting residues on the talin surface.
LD-recognition box is marked by a red rectangle.
(D) Talin-interacting residues on the surface of
DLC1 helix. The helix is rotated by 180 around the
vertical axis relative to the orientation in (B).
(E) Sequence alignment of DLC1 with RIAM TBS
and paxillin LD domains. Peptide fragments used
to solve the structures of the complexes are un-
derlined. Residues involved in the interactions with
the corresponding proteins are highlighted in
magenta (hydrophobic interactions) and orange
(charged and hydrophilic interactions). Red box
indicates the DLC1 LD-motif identified from
sequence comparison. For paxillin LD1 the un-
derlined region corresponds to the LD motif. Po-
sitions of the coiled-coil heptad repeat are shown
above the sequences. The underlined positions
‘‘a’’ and ‘‘d’’ correspond to the interacting hydro-
phobic residues in coiled coils.
(F) Comparison of the positions of DLC1 and RIAM helices in the complexes with the talin R8 domain.
(G) Locations of the hydrophobic residues on the surfaces of the DLC1 and RIAM helices involved in the interaction with talin R8. The helices are rotated by 180
around the horizontal axis relative to the orientation in (F).
See also Figure S1.the results support the roles of the charged residues in DLC1
recognition by talin.
Comparison of DLC1, RIAM, and Paxillin Complexes
The talin binding LD motif of DLC1 interacts with the LD binding
FAT domain of FAK and was initially identified through its homol-
ogy with paxillin LD motifs (Li et al., 2011). From the sequence
homology and structural similarity, we predicted that paxillin
LD motifs should also interact with the talin R8 domain. Indeed,
we observed large chemical-shift changes in the 1H,15N-HSQC
spectra of talin R8 and R7R8 on addition of paxillin LD1 (Figures
5A and S2C) and LD2 peptides (data not shown). The amplitudes
of the chemical-shift changes were comparable with those
induced by DLC1 (compare with Figure 1D), although a smaller
number of resonances were affected. The chemical-shift
changes map predominantly to the LD motif binding region of
the talin R8 domain (Figure 5B). No chemical-shift changes
were detected on the interfaces formed by other R8 helices,
demonstrating that R8 has only a single LDmotif binding site un-
like the FAT domain of FAK, which has two (Figure 5B) (Hayashi
et al., 2002; Hoellerer et al., 2003).
Overall, the topology of the R8/DLC1 and FAK/paxillin com-
plexes is similar, and binding is mediated by similar residues
(Figures 3E and 5B), suggesting that the paxillin LD motif inter-
acts with the LD-recognition box in talin R8. In this orientation
only a single ion pair between K1544 of talin R8 and the D residue
of the paxillin LDmotif is expected to form, potentially making the
contribution from this contact more prominent. Consistent with1134 Structure 24, 1130–1141, July 6, 2016this prediction, we detected only minor chemical-shift changes
in the K1544E talin R7R8 mutant on addition of paxillin LD1
(Figure 5C).
Using an LD motif deletion mutant of DLC1, we previously
demonstrated that the DLC1/talin interaction contributes to
DLC1-adhesion targeting (Li et al., 2011). To assess whether
the interaction with talin R8 has similar effect on paxillin localiza-
tion, we compared talin/paxillin and talin/DLC1 ratios in talin1
and talin2 knockout (TKO) cells (Atherton et al., 2015) transfected
either with wild-type talin or a talin mutant lacking the R8 domain
(talDR8). The relative abundance of both DLC1 and paxillin in
adhesions was significantly and comparably reduced in cells ex-
pressing talDR8 (Figure 5D). Reduced DLC1 localization was
analogous to what we had seen earlier with the DLC1 mutant
(Li et al., 2011), providing independent evidence that talin R8 is
the interaction site for DLC1, thus validating our approach. The
reduced localization of paxillin in FA provides the first evidence
that talin directly contributes to paxillin recruitment to FA.
Besides DLC1 and paxillin, the R8 domain also binds RIAM
(Goult et al., 2013b). The recently reported structure of the R8/
RIAM complex (PDB: 4W8P) (Chang et al., 2014) shows that,
similar to DLC1, RIAM forms a helix that fits into the hydrophobic
groove of the a2 and a3 helices of talin R8 (Figure 3F; Chang
et al., 2014). Although not identified as an LDmotif, the sequence
of RIAM has a characteristic distribution of negatively charged
and hydrophobic residues (Figure 3E) that explains the interac-
tion with the LD-recognition surface of R8. In support for the
similarity of DLC1 and RIAM recognition by R8, we observed a
Figure 4. Interactions of Charge-Reversal Mutations of Talin R7R8 and DLC1(461–489)
(A) Location of the mutated residues in the structure of talin R8/DLC1(467–489) complex.
(B–F) Superposition of the HSQC spectra of 0.2 mM talin R7R8 free (blue) and in the presence of 0.8 mM DLC1(461–489) (red). Mutations are marked on the
spectra. wt, wild-type form of the protein.
See also Figure S2.strong reduction in RIAM binding affinity for the R1530E/K1544E
mutant (Figures S2E and S2F).
Interestingly, in the R8/RIAM complex (Chang et al., 2014) the
RIAM helix has an unusual kink, which causes its displacement
relative to DLC1 (Figure 3F). However, the critical hydrophobic
side chains that make contacts with the surface of talin R8 are
located in similar positions, and make contacts with similar res-
idues on R8, particularly at the N- and C-terminal ends of the he-
lices (Figure 3G). These residues occupy equivalent positions in
the sequences of the two proteins, showing that the DLC1 and
RIAM helices are generally in register relative to each other
(Figure 3E).The kink in the RIAM helix appears to be forced by the hydro-
phobic contacts of the aromatic ring of F12, which is inserted be-
tween helices a2 and a3 of talin R8. In DLC1, the equivalent L473
occupies a peripheral position and is partly exposed to solvent.
The helical kink is energetically unfavorable, but may be partially
compensated by the hydrogen bond involving RIAM S13, as
suggested byChang et al. (2014). Significantly, no kink is present
in the RIAM helix in complex with vinculin determined by X-ray
crystallography (Goult et al., 2013b), nor with the talin F3 domain
determined by NMR (Yang et al., 2014). These arguments sup-
port an induced kink model, rather than a stable kinked helix
model proposed by Chang et al. (2014). Additional contributionsStructure 24, 1130–1141, July 6, 2016 1135
Figure 5. Interaction of Paxillin LD Motifs with Talin R8
(A) Superposition of the HSQC spectra of 0.1 mM talin R8 free (red) and in the presence of 0.4 mM paxillin LD1 (blue).
(B) Comparison of structures of talin R8/DLC1 and FAK/paxillin complexes. From left to right: side view of the R8/DLC1 complex—the DLC1 helix is in orange with
the LD motif highlighted in red; front view of the R8/DLC1 complex—largest chemical-shift perturbations caused by LD1 binding are highlighted in purple;
structure of the FAK complex with LD2 bound to the 2–3 site (helices a2 and a3) and LD4 bound to the 1–4 site (helices a1 and a4) (PDB: 1OW7).
(C) Superposition of the HSQC spectra of 0.2 mM talin R7R8 K1544E mutant free (red) and in the presence of 0.8 mM paxillin LD1 (blue).
(D) Ratio imaging was used to determine the proportion of endogenous paxillin and DLC1 present at FA in TKOs expressing either talin FL or talin DR8.
Quantitative analysis shows that both paxillin and DLC1 are markedly reduced in adhesions when talin R8 is deleted (n = 20 cells from three independent ex-
periments). Error bars are ± SEM. **p < 0.01, ***p < 0.001 (ANOVA). White line indicates cell margin. Scale bar, 10 mm.
See also Figures S2 and S3.to the kink in the RIAM helix may be due to crystal packing
(Figure S1D).
Changes in the NMR spectra of R8 on ligand addition suggest
different affinities for the interactions between talin and DLC1,
RIAM, and paxillin. The strongest effects on the spectra were
observed for RIAM, where many signals shifted and broadened
significantly at R8/peptide ratio as low as 1:0.1. For DLC1 similar
broadening and shifts were observed, but required a higher ratio
of 1:0.5, while for paxillin only chemical-shift changes were
detected. For each peptide, the chemical-shift changes of the
signals that showed only limited broadening throughout the
titration (corresponding to a fast exchange regime) could be
successfully fitted to the theoretical binding curves, with similar
dissociation constants (Figure S3). In agreement with the quali-
tative analysis, the KD values determined by fitting were 48, 3.5,
and 168 mM for DLC1, RIAM, and paxillin, respectively. Overall,
the measured KD values are within the range of the low to high-
micromolar values reported for biologically relevant LD-motif
interactions (Alam et al., 2014), and the value for RIAM is in
excellent agreement with that reported earlier (Chang et al.,
2014). The high affinity of talin R8 for RIAM likely reflects the
larger contribution of hydrophobic side chains to binding, while
the lower affinity for paxillin correlates with the smaller binding
region.1136 Structure 24, 1130–1141, July 6, 2016Biological Implications for DLC1-Talin Interaction from
Mutational Analysis
We reported previously that wild-type talin R8 is sufficient to
form a complex with full-length DLC1 in cells (Li et al., 2011).
To evaluate the effects of the single K1530E and K1544E and
double K1530E/K1544E (2E) R8 mutants on the complex forma-
tion in vivo, we engineered GST-tagged R8 constructs into
isogenic mammalian expression plasmids and co-transfected
them with GFP-DLC1 into HEK 293T cells. Complex formation
was determined by a GST pull-down assay. Consistent with
the NMR results, the talin R8 K1530E mutation caused a greater
reduction in DLC1 binding than K1544E, while the 2E double
mutant reduced binding to a greater extent than either single
mutant (Figure S2D).
We next compared the ability of the wild-type talin R8 and
mutant constructs to compete with binding of endogenous talin
to GFP-DLC1 in cells, to see whether the GFP-DLC1-dependent
biological effects require the interaction with talin R8. For
this experiment we used three pairs of GST-tagged talin
constructs that each contained R8; (1) the wild-type talin R8
and 2E constructs described above (encoding amino acids
1,453–1,580), (2) talin R7R8 and equivalent 2E constructs (en-
coding amino acids 1,352–1,580), and (3) wild-type and 2E
talin constructs spanning residues 1,288–1,646 that were used
Figure 6. Talin R8 Mutations Disrupt the Interaction with DLC1 and Affect Its Biological Activity
(A) Wild-type GST-talin fragments pull down more DLC1 than the 2E mutants. Extracts of HEK293T cells transfected with GFP-DLC1 and GST-talin constructs
were subjected to pull-down assays with glutathione beads followed by immunoblotting with anti-GST and anti-DLC1 on the same membrane (top). The
transfected GFP-DLC1 in each sample is shown by the anti-DLC1 blot (bottom) as a loading control.
(B)Wild-type GST-talin fragments compete efficiently with endogenous talin to form a complexwith DLC1. The supernatants collected after pull-down assay from
(A) were reused for co-immunoprecipitation with an anti-talin antibody and blotted with anti-DLC1 (top). A small aliquot from each lane was blotted for
endogenous talin as a loading control (bottom).
(C) Co-expression of GST or GST-talin fragments (wild-type or 2Emutant) with GFP DLC1 in A549 cells. Six days after transfection, A549 cell lysates were blotted
with anti-DLC1 (top) and anti-GST (bottom) to conform equal protein expression.
(D) G418 colony growth assay. Transfected A549 cells were cultured in G418 for 3 weeks, and colonies counted and quantitated (top). Representative stained
colonies are shown (bottom).
(E) Growth in soft agar. Transfected A549 cells were grown for 3 weeks in soft agar, and colonies counted and quantitated (top). Representative stained whole
dishes are shown (bottom).
(F) Transwell cell migration assay. Lysates from migrated cells were quantitated (top), and representative microscopic images of the migrated cells are shown
(bottom).
The results in (D–F) are represented as means over three experiments ± SD. See also Figures S4–S6.previously (Li et al., 2011). GST served as negative control in the
assay. We first confirmed that complex formation with GFP-
DLC1 as determined by GST pull-downs was greater for eachwild-type talin fragment than for the respective 2E mutant
(Figure 6A). The wild-type versions of each talin construct
should therefore compete with endogenous talin for binding toStructure 24, 1130–1141, July 6, 2016 1137
GFP-DLC1more effectively than the 2Emutant. Talin was immu-
noprecipitated from the supernatants of the GST pull-downs and
blotted for GFP-DLC1 to evaluate this; co-expression of GST
with DLC1 or with vector served, respectively, as a positive
and negative control (Figure 6B). Substantially less GFP-DLC1
co-immunoprecipitated with talin in cells co-transfected with
constructs containing wild-type R8 versus the 2E mutants (Fig-
ure 6B). We conclude that each wild-type GST-talin polypeptide
inhibits binding of GFP-DLC1 to endogenous talin more effec-
tively than the respective 2E mutant.
To assess the biological effects of inhibiting the interaction be-
tween endogenous talin and GFP-DLC1, we tested the ability of
each talin wild-type and 2Emutant pair to antagonize the activity
of co-transfected GFP-DLC1 in the A549 human non-small cell
lung cancer line. Equivalent expression levels of each talin
construct were confirmed by western blotting (Figure 6C). We
used three different bio-assays (for details see Supplemental
Experimental Procedures): monolayer colony growth (Figure 6D),
growth in soft agar (Figure 6E), and transwell cell migration (Fig-
ure 6F). In the absence of any co-transfected talin fragment,
GFP-DLC1 was inhibitory in all three assays, while the GST-R8
talin construct (wild-type or 2E mutant) by itself had no detect-
able biological activity, as its effects were similar to that of the
GST negative control (Figure S4). However, each wild-type talin
polypeptide attenuated the inhibitory activity of GFP-DLC1 in all
three bio-assays, consistent with its efficient displacement of
endogenous talin from GFP-DLC1. By contrast, each 2E mutant
had only a marginal effect on the inhibitory activities of GFP-
DLC1. The results clearly demonstrate that the biological activity
of DLC1 is associated with its interaction with talin and confirm
the importance of the talin R8 residues K1530 and K1544 to
the interaction.
However, as talin R8 interacts with RIAM (Goult et al., 2013b)
and paxillin (shown here) in addition to DLC1, we used several
approaches to evaluate whether binding of talin R8 to endoge-
nous RIAM or paxillin might have contributed to the observed re-
sults. For RIAM, the level of expression in the cell lines used here
varied from very low to undetectable. To detect RIAM protein in
any of the cell extracts, we had to use an anti-RIAM immunopre-
cipitation step followed by anti-RIAM immunoblotting. Using
these conditions, endogenous RIAM was detected in A549 and
H358 cells, but not in 293T cells (Figure S5A). In A549 cell ex-
tracts, which contain endogenous RIAM, anti-RIAM immuno-
blotting did not detect a GST-R8 complex (Figure S5B, left),
whereas the wild-type GST-R8, but not the 2E mutant, did bind
GFP-DLC1 under the same conditions (Figure S5B, right). The
failure to detect an R8/RIAM complex despite the higher affinity
of R8 for RIAM versus DLC1 suggests that the biological effects
induced by GST-R8 are unlikely to be mediated via RIAM.
To investigate whether the biological effects of GST-R8 might
be partly mediated via paxillin, we first confirmed that endoge-
nous paxillin is expressed in cell lines A549, H358, and 293T
(Figure S6A). However, the levels of endogenous paxillin in
A549 and H358 cells, in combination with its relatively low
affinity for DLC1, were insufficient to detect binding to GST-R8
using the pull-down assay (Figure S6B top and bottom, respec-
tively). As a positive control, HEK293 cells were co-transfected
with a paxillin-DDK construct (OriGene) and GST-R8 (wild-
type, R1544E and 2E mutants), followed by a GST pull-down1138 Structure 24, 1130–1141, July 6, 2016assay. Under these conditions, wild-type GST-R8 did bind pax-
illin-DDK, and did so more efficiently than 2E GST-R8 talin
mutant (Figure S6C).
Taking these data together, we conclude that the ability of
wild-type GST-talin R8 to inhibit growth and migration in A549
cells is largely attributable to its interaction with DLC1, as no ef-
fect was observed in the absence of DLC1, and binding to
endogenous RIAM and paxillin in cell extracts was undetectable
under conditions associated with a strong DLC1 interaction.
DISCUSSION
The interaction between talin and DLC1 plays a key role in re-
cruiting DLC1 to FAs and contributes to the tumor-suppressor
activity of DLC1 (Li et al., 2011). Although deletion analysis has
been successfully used to identify regions that are critical for talin
interaction with DLC1 (Li et al., 2011), the exact location of the
binding sites and the mechanism of the interaction have re-
mained unknown. Here, we refine the boundaries of the TBS in
DLC1 and report the crystal structure of this region in complex
with the talin R7R8 rod domains. Analysis of the structure iden-
tifies the general features of the DLC1 binding site in the talin
R8 four-helix bundle and the specific residues involved. Thus,
a talin R8 K1530E/K1544E double mutant markedly reduced
binding to DLC1 peptides in vitro, and to full-length DLC1 in cells,
compromising the ability of GST-talin R8 constructs to displace
DLC1 from endogenous talin and thereby to attenuate the tumor-
suppressor activity of DLC1. Sequence similarity between the
TBS in DLC1 and paxillin LDmotifs suggested a possible interac-
tion between talin and paxillin, and we have confirmed this novel
interaction by NMR and have shown that it is an important factor
in determining paxillin levels in FAs. Taken together, our results
explain how talin R8 recognizes LDmotifs in both DLC1 and pax-
illin, and suggest that talin forms part of an LD-motif-based
network of interacting proteins that contribute to the assembly
and regulation of adhesion complexes.
Our structure of the talin R7R8/DLC1 complex demonstrates
that the TBS in DLC1 forms a helix that packs against the two
adjacent a2 and a3 helices of the talin R8 four-helix bundle in a
consensus left-handed triple-helix coiled-coil arrangement.
The DLC1 binding site in talin is fully accessible to solvent, and
the conformation of the R8 domain does not change on binding.
The resulting five-helix coiled-coil complex can be classified as a
hybrid conjoined three-/four-stranded coiled coil (Moutevelis
and Woolfson, 2009). A similar structure is formed in the talin
R8/RIAM (Chang et al., 2014) and paxillin/FAK (Hoellerer et al.,
2003) complexes. Although classified as a rare fold (Moutevelis
andWoolfson, 2009), the three-/four-stranded coiled coil is likely
to be a relatively common topology for complexes between four-
helix bundles and isolated helices, as it minimizes the rearrange-
ment of the four-helix core.
Recognition that the interaction between DLC1 and talin R8 in-
volves coiled-coil packing allowed us to analyze the interaction,
usingwell-established rules for coiled-coil structures. The TBS in
DLC1 contains a typical heptad repeat identified in left-handed
coiled coils (Lupas and Gruber, 2005) (Figure 3) that creates a
hydrophobic interaction surface. Flanking this region are polar
residues that contact complementary polar residues in talin
R8. We identified three regions on the talin R8 surface that aid
recognition of the DLC1 helix: (1) an LD-recognition box consist-
ing of a hydrophobic cluster with an embedded positive charged
amino acid that matches the consensus LD motif, (2) a polar
ridge that generates a network of polar contacts and hydrogen
bonds between DLC1 and R8, and (3) a small hydrophobic patch
that contacts the C-terminal hydrophobic residues of the DLC1
helix. In addition, the R8 binding surface lacks any charged or
large polar residues along the whole interface between the a2
and a3 helices, thus avoiding any unfavorable contacts with
the hydrophobic residues in the middle of the DLC1 helix.
Together, these features create a complementary surface that
can accommodate the entire length of the DLC1 TBS helix
(Figure 3).
Among the contacts identified between DLC1 and talin R8,
charge complementarity within the polar ridge (Figure 3) is likely
to define ligand selectivity. We confirmed this prediction by
reversing the charges of K1530 and K1544 at opposite ends
of the binding region in R8. While double charge reversal
completely abolished DLC1 binding, single charge reversals
had only a partial effect, demonstrating that both interactions
contribute to ligand recognition. Paxillin LD motifs form signifi-
cantly shorter helices that correspond to the N-terminal half of
the DLC1 helix, and interact only with the LD-recognition box.
In this case charge reversal of K1544 in the LD-recognition box
of R8 (Figure 3C) had a much stronger effect on the interaction
with paxillin, practically abolishing binding. This observation
highlights charge complementarity as a general feature of LD
motif recognition, with additional contributions outside the LD
box fine-tuning the interactions with specific ligands.
Our results further support the important contributions of weak
interactions to the adhesion mechanisms. Despite the relatively
low affinities of DLC1 and paxillin for talin R8 (KD of 48 and
168 mM, respectively), these interactions can be detected in
cells, and their disruption strongly reduces the abundance of
DLC1 and paxillin in FAs (Figure 5D). For DLC1 this affects adhe-
sion-dependent colony growth and migration, although the bio-
logical role of the talin-paxillin interaction is currently unclear and
will need further investigation. Large differences in the dissocia-
tion constants of DLC1, RIAM, and paxillin interactions with talin
R8 are in line with the low- to high-micromolar range of constants
determined for other LD motif interactions (Alam et al., 2014).
These interactions are likely to be enhanced through the high
concentration of the binding sites within adhesion complexes.
Although not previously identified as an LD motif, the N-termi-
nal part of the TBS in RIAM shows a pattern similar to that of
DLC1, with hydrophobic and charged residues that fit the LD-
recognition box in talin R8 (Figure 3). DLC1 also binds to the
FAK FAT domain, a recognized partner for paxillin LD motifs,
and R8 itself interacts with paxillin. Extending this set of interac-
tions, other LD motif binding proteins that have four-helix bundle
structures, such as PYK2 (Alam et al., 2014), may also interact
with DLC1 and RIAM. In turn, LD motifs of other proteins,
including members of the paxillin family, such as leupaxin and
Hic-5, may interact with talin. The combination of an LD-like helix
and a four-helix bundle containing an LD-recognition boxmay be
a common feature among interacting adhesion proteins serving
alongside other interacting pairs such as SH3 domain/polypro-
line sequences. The critical contribution of charged residues to
recognition of the LD motif and additional interactions outsidethe LD motif can be used to selectively modulate the binding
of specific ligands, as we demonstrated for DLC1, paxillin, and
RIAM using charge-reversal mutations.
Comprehensive analysis of talin has revealed multiple ligand
binding sites in the 13 talin rod domains, often arranged in com-
plex overlapping patterns (Goult et al., 2013b). There are 11
VBSs in the talin rod, and the talin/vinculin interaction plays a
key role in stabilizing FAs (Carisey et al., 2013). There are five pu-
tative RIAM binding sites in talin (four in the rod) that have the po-
tential to regulate the initiation of adhesion complex assembly
(Goult et al., 2013b; Yang et al., 2014). In addition, we now iden-
tify a paxillin binding site in the talin rod, and more talin interac-
tions may be discovered. In turn, RIAM itself has two TBSs that
can also bind vinculin (Goult et al., 2013b), and paxillin has five
LD motifs, several of which interact with vinculin and FAK (Hoell-
erer et al., 2003). A direct link between talin and FAK has also
been reported (Lawson et al., 2012; Lawson and Schlaepfer,
2012), although molecular details of this interaction are missing.
DLC1 has at least one binding site that interacts with talin and
FAK in a similar way. All these interactions create a complex
network at the core of adhesion complexes, where mechano-
sensing molecules such as talin and vinculin link to each other
and to signalingmolecules such as FAK andDLC1, either directly
or indirectly, through adaptor proteins such as RIAM and paxillin.
Strikingly, all talin rod five-helix bundles, except the C-terminal
R13 actin-binding domain (Gingras et al., 2008; Goult et al.,
2013b), have the same conjoined three-/four-stranded coiled-
coil topologies. The significance of this is currently not under-
stood, although some speculation can be made based on
comparison with the DLC1/talin R8 complex, which has the
same helix arrangement as a talin rod five-helix bundle (Figure 2).
The core of the fold is a typical four-helix bundle that is likely to
remain stable when the N-terminal a0 helix is removed: the talin
R8 four-helix bundle is perfectly stable in the absence of DLC1,
and removal of the N-terminal a0 helix from the R10 domain gen-
erates a stable four-helix bundle (Gingras et al., 2006; Goult
et al., 2010) that is similar to R8. This suggests that under
some conditions, talin five-helix domains may exist as four-helix
bundles, raising the exciting possibility that removal of the a0
helix might expose cryptic binding sites that can interact with
helical regions homologous to the a0 sequence. The VBSs in
the talin rod are buried in the hydrophobic core of the helical bun-
dles in which they are contained (Calderwood et al., 2013), and
force exerted on talin is required to expose these sites (del Rio
et al., 2009; Yao et al., 2014). It is therefore tempting to speculate
that force may also play a role in displacing the a0 helix in talin
rod five-helix bundles, exposing cryptic binding sites for proteins
such as those containing LD motifs.
Although talin is widely recognized as a key player in adhesion
complex assembly, the extent of the talin interaction network is
unclear, and no comprehensive proteomic study on talin binding
partners has been reported. Rather, the majority of studies have
concentrated on individual interactions that are often prominent
under specific conditions. Experiments in live cells demonstrate
that adhesion complex assembly has a high tolerance for dele-
tion of individual proteins, as well as deletions or mutations of in-
dividual binding sites. This implies a high level of redundancy in
the system, some of which may be due to the multi-site interac-
tions between FA proteins.Structure 24, 1130–1141, July 6, 2016 1139
EXPERIMENTAL PROCEDURES
Peptides and Protein Preparation
Recombinant wild-type mouse talin1 fragment R7R8 (residues 1,357–1,653)
was previously cloned into pET151/D-TOPO expression vector (Gingras
et al., 2010). Site-directed R7R8 mutants were produced by overlap extension
PCR and subsequent ligation-independent cloning into pOPINB vector (OPPF-
UK). Protein was produced in BL21 STAR (DE3) cultured in Luria-Bertani or
23M9minimal medium containing 1 g/l 15N-labeled NH4Cl, and purified using
nickel-affinity chromatography followed by ion exchange.
X-Ray Crystallography
Sitting-drop sparse matrix crystallization screens were set up using a 300-mM
solution of talin R7R8 fragment in the presence of 8-fold molar excess of
DLC1(467–489) peptide. Crystals were obtained in 15% ethanol and 0.1 M
Tris (pH 7.4) at 4C and vitrified in sodium malonate (pH 7) prior to data collec-
tion. The DLC1/R7R8 complex was solved using molecular replacement using
the structure of the free R7 domain as a template (PDB: 2X0C) (Gingras et al.,
2010). Initial electron density maps showed that the position of the R8 domain
had changed, and once repositioned and the R7R8 domain modeled, electron
density for the DLC1 peptide was clearly visible, as demonstrated in the
simulated annealing composite omit map (Figure S1A). Refinement was per-
formed using isotropic B factors, and at the final stage of refinement employed
the use of TLS parameters. Data reduction and refinement statistics are shown
in Table 1.
NMR Spectroscopy
NMR spectra were collected on Bruker Avance III 600- and 800-MHz spec-
trometers equipped with CryoProbes. Experiments were performed at 298 K
in 20 mM sodium phosphate (pH 6.5) and 50 mM NaCl with 5% (v/v) 2H2O.
Dissociation constants were evaluated from the 1H,15N-HSQC chemical-
shift changes in the titration experiments conducted using 0.1 mM [15N]talin
R8 domain. Peptides were added from 5- to 10-mM stock solutions to
generate titration points at peptide/protein ratios 0.1, 0.2, 0.5, 0.75, 1, 2,
4, and 8.
Cell-Based Assays
The plasmids expressing GFP-DLC1 and GST fusion proteins with talin rod
fragments encoding talin amino acids 1,288–1,646 and 1,453–1,580 (R8)
were described previously (Li et al., 2011). The plasmid encoding 1,352–
1,580 (R7R8) was engineered by PCR and subcloned into a eukaryotic
expression vector, PEBG. HEK293T cells were transfected by Lipofectamine
2000, and DLC1-null lung adenocarcinoma cell lines A549 and H358 cells
were transfected by Lipofectamine 3000 according to the manufacturer’s in-
structions (Invitrogen). Cells were co-transfected with plasmids expressing
GFP-DLC1 or Paxillin-DDK and GST, GST-talin fragments, or vector at a
ratio of 1:2.5. Cells were incubated at 37C in a humidified 5% CO2 atmo-
sphere. In vivo pull-down assay, co-immunoprecipitation, immunoblotting,
G418 colony growth, soft agar growth, and cell migration assays were
described previously (Qian et al., 2009). All experiments were conducted in
triplicate.
Ratio Imaging
Talin1 and talin2 knockout cells were generated and cultured as described in
Atherton et al. (2015). Transient transfections were performed using Lipofect-
amine and Plus reagents (Life Technologies) as per themanufacturer’s instruc-
tions. Cells transfected with GFP-talin proteins were incubated overnight on
glass-bottomed dishes (MatTek), fixed with 4% paraformaldehyde and per-
meabilized with 0.5% Triton X-100 (Sigma). Samples were incubated with
the primary antibody for 60 min and then washed thrice with PBS. Secondary
antibody staining followed the same procedure. Fixed samples were imaged
using a Delta Vision RT microscope (Applied Precision) equipped with a
603/1.42 Plan Apo oil-immersion objective (Zeiss). Images were acquired
with a CoolSnap HQ camera (Photometrics). Images were background sub-
tracted, a region of interest was selected around an individual peripheral adhe-
sion (five per cell), and the integrated density measured for both channels.
Dividing the values from paxillin or DLC1 by talin then produced a ratio.
Further details can be found in Supplemental Experimental Procedures.1140 Structure 24, 1130–1141, July 6, 2016ACCESSION NUMBERS
The coordinates for the structure of the talin R8/DLC1 complex have been
deposited in the PDB under accession code PDB: 5FZT. Backbone chemical
shifts of the talin R8 have been deposited in the Biological Magnetic Reso-
nance Bank under accession code BMRB: 19339.
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